Position in SEER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$270,275
-$43,327 QoQ
Shares Held
160,879
-6.1% QoQ
Ownership
0.293%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. SEER ranks #317 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $270,275 | 160,879 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $313,602 | 171,368 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $413,303 | 190,463 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $596,157 | 278,579 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $558,910 | 330,717 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,348,121 | 583,603 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $416,464 | 211,404 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $533,481 | 317,550 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $790,513 | 416,061 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $880,959 | 454,104 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $459,604 | 207,967 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,387,183 | 324,868 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $920,548 | 238,485 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,069,448 | 184,388 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,426,842 | 830,342 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,575,713 | 734,717 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $12,441,247 | 816,355 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $30,623,926 | 1,342,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $34,633,068 | 1,002,985 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,846,916 | 666,471 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $25,982,788 | 519,448 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $45,779,138 | 815,446 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||